Protea Fund - Sectoral Biotech Opportunities Fund Class PF Fonds
8,55
USD
+0,07
USD
+0,83
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Gilead Sciences Inc | US3755581036 | 9,93% |
| Amgen Inc | US0311621009 | 7,66% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 7,01% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 6,01% |
| AstraZeneca PLC ADR | US0463531089 | 4,44% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,98% |
| argenx SE ADR | US04016X1019 | 3,37% |
| Biomarin Pharmaceutical Inc | US09061G1013 | 2,68% |
| BeiGene Ltd ADR | US07725L1026 | 2,47% |
| Summit Therapeutics Inc Ordinary Shares | US86627T1088 | 2,47% |
| Sonstige | 50,00% |